Occupancy of platelet receptors for platelet-activating factor in asthmatic patients during an allergen-induced bronchoconstrictive reaction.

Journal of lipid mediators Pub Date : 1993-06-01
J A Burgers, P L Bruynzeel, H J Mengelers, J Kreukniet, J W Akkerman
{"title":"Occupancy of platelet receptors for platelet-activating factor in asthmatic patients during an allergen-induced bronchoconstrictive reaction.","authors":"J A Burgers,&nbsp;P L Bruynzeel,&nbsp;H J Mengelers,&nbsp;J Kreukniet,&nbsp;J W Akkerman","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The administration of platelet-activating factor (PAF) to human subjects triggers asthma-like responses. We investigated whether a bronchoconstrictive reaction was accompanied by the release of PAF in the circulation of allergic asthmatics. The appearance of PAF was assessed by measuring the number of freely accessible PAF-receptors on platelets in vitro, assuming that the contact between platelets and PAF in vivo would reduce the receptor binding of [3H]PAF in vitro. 16 asthmatics were challenged twice, first with buffer and the next day with allergen. A comparison between receptor binding after provocation with the data of the same patients after allergen challenge revealed a significant difference in PAF binding (P = 0.034), with an average decrease of 14% immediately after allergen challenge followed by a return to control values after about 4 h and a transient increase of 9% at 7 h after provocation. The decrease in accessible PAF receptors was accompanied by a slight decrease in platelet count in peripheral blood between 30 min and 4 h after allergen challenge. The platelet counts recovered to the original values afterwards. These data support the concept that in patients with allergic asthma PAF is secreted in the circulation. The contact between PAF and the platelets may trigger the transient sequestration of platelets, possibly in the lung. Thus, PAF and platelets may contribute to the pathogenesis of allergic asthma.</p>","PeriodicalId":16323,"journal":{"name":"Journal of lipid mediators","volume":"7 2","pages":"135-49"},"PeriodicalIF":0.0000,"publicationDate":"1993-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of lipid mediators","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The administration of platelet-activating factor (PAF) to human subjects triggers asthma-like responses. We investigated whether a bronchoconstrictive reaction was accompanied by the release of PAF in the circulation of allergic asthmatics. The appearance of PAF was assessed by measuring the number of freely accessible PAF-receptors on platelets in vitro, assuming that the contact between platelets and PAF in vivo would reduce the receptor binding of [3H]PAF in vitro. 16 asthmatics were challenged twice, first with buffer and the next day with allergen. A comparison between receptor binding after provocation with the data of the same patients after allergen challenge revealed a significant difference in PAF binding (P = 0.034), with an average decrease of 14% immediately after allergen challenge followed by a return to control values after about 4 h and a transient increase of 9% at 7 h after provocation. The decrease in accessible PAF receptors was accompanied by a slight decrease in platelet count in peripheral blood between 30 min and 4 h after allergen challenge. The platelet counts recovered to the original values afterwards. These data support the concept that in patients with allergic asthma PAF is secreted in the circulation. The contact between PAF and the platelets may trigger the transient sequestration of platelets, possibly in the lung. Thus, PAF and platelets may contribute to the pathogenesis of allergic asthma.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
哮喘患者在过敏原诱导的支气管收缩反应中血小板活化因子受体的占用。
给人服用血小板活化因子(PAF)会引发类似哮喘的反应。我们研究了过敏性哮喘患者的支气管收缩反应是否伴随着PAF的释放。通过测定体外血小板上可自由接近的PAF受体的数量来评估PAF的出现,假设体内血小板与PAF的接触会减少体外[3H]PAF的受体结合。16例哮喘患者接受两次挑战,第一次用缓冲液,第二天用过敏原。将激射后的受体结合与同一患者激射后的数据进行比较,发现PAF结合有显著差异(P = 0.034),激射后立即平均下降14%,约4小时后恢复到对照值,激射后7小时短暂增加9%。在过敏原攻击后30分钟至4小时内,可达PAF受体的减少伴随着外周血血小板计数的轻微减少。术后血小板计数恢复到原来的水平。这些数据支持了过敏性哮喘患者在循环中分泌PAF的概念。PAF与血小板之间的接触可能触发血小板的短暂隔离,可能在肺中。因此,PAF和血小板可能参与过敏性哮喘的发病机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Differential sensitivity of mouse strains to platelet activating factor-induced vasopermeability and mortality: effect of antagonists. 5-Lipoxygenase activity in the human pancreas. PAF-releasing factor in human serum and inflammatory exudate. Secretory non-pancreatic group II phospholipase A2: role in physiologic and inflammatory processes. Sphingosine and sphingosine 1-phosphate in cellular proliferation: relationship with protein kinase C and phosphatidic acid.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1